Who
Michael Carulli
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, PMV Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $34K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jan 2024
- Last trade
- 5 Mar 2026
- Last filed
- 9 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Mar 2026filed 9 Mar 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $30K28,249 at $1.06 | filing |
| 3 Mar 2025filed 5 Mar 2025 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —265,000 at $0.00 | filing |
| 11 Sep 2024filed 12 Sep 2024 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,3372,891 at $1.50 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —13,605 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —27,200 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,805 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —75,000 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 | filing |
| 18 Jan 2024filed 22 Jan 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —204,630 at $0.00 | filing |
| 18 Jan 2024filed 22 Jan 2024 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —82,220 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.